---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-058621"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:48:20.266413+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Unicycive amends OLC manufacturing deal with Shilpa, secures binding purchase order

## Summary
- Binding purchase order for OLC tablets; delivery by June 30, 2025.
- Additional OLC tablet orders required between Dec 31, 2025 and June 30, 2026.
- Company to provide funding to Shilpa for a new manufacturing line.
- Initial term extended to 8th anniversary of FDA approval of OLC NDA.

## SEC filing metadata
- accession: 0001213900-24-058621
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/0001213900-24-058621-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/ea0208854-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-058621
- JSON: https://secwatch.observer/filing/0001213900-24-058621.json
- Plain text: https://secwatch.observer/filing/0001213900-24-058621.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.